Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs KDB Tifa Finance Tbk. (TIFA)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan KDB Tifa Finance Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan KDB Tifa Finance Tbk. diperdagangkan di Rp316 (kapitalisasi pasar 1,14 T, volume 24 jam 10,2 rb). Perbedaan utamanya: KDB Tifa Finance Tbk. jauh lebih besar — sekitar 10,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TIFA | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 1,14 T |
Volume | — | 10,2 rb |
Lot | — | 102 |
Perputaran | — | 3,26 jt |
Harga Rata-rata | — | 320,02 |
Nilai Transaksi | — | 3,26 jt |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang KDB Tifa Finance Tbk.
PT Tifa Finance Tbk (the company) was established under its original name of PT Tifa Mutual Finance Corporation base on notarial deed No.42 of Esther Daniar, S.H, dated on 14 Jun, 1989. The Company’s articles of association has been amended several times, most recently by notarial deed No. 1 of Fathiah Helmi, S.H., dated Aug 2, 2010, concerning among others, the change in the Company’s name, and public offering.
Selengkapnya di halaman TIFA →
